Success predictive factors of a multimodal treatment consisting of Manual Therapy, Therapeutic Exercises and Pain Education in individuals with Temporomandibular Disorders

Start Date01 Jan 2023

Sponsor / Collaborator

Faculdade De Medicina De Ribeirão Preto

[+1]

RBR-5x7z9zf / RecruitingNot ApplicableIIT

Effects of acute modafinil administration on learning conditional relationships and emergence of stimulus equivalence in the elderly

Start Date15 Oct 2022

Sponsor / Collaborator

Faculdade De Medicina De Ribeirão Preto

[+1]

100 Clinical Results associated with Faculdade De Medicina De Ribeirão Preto

0 Patents (Medical) associated with Faculdade De Medicina De Ribeirão Preto

401

Literatures (Medical) associated with Faculdade De Medicina De Ribeirão Preto

01 Sep 2024·IJID Regions

Multisystem inflammatory syndrome in children across 16 Latin American countries: A multicenter study from the REKAMLATINA Network

Article

Author: Luciani, Kathia ; Espada, Graciela ; Cantillano, Edwin M ; Chacon-Cruz, Enrique ; Llamas-Guillén, Beatriz A ; Martínez-Ramírez, Rogelio O. ; Yamazaki-Nakashimada, Marco A ; Ulloa-Gutierrez, Rolando ; Duarte-Passos, Saulo ; Criales, Javier ; Velásquez-Méndez, Mónica ; Aguilar, Karla L Borjas ; Yamazaki-Nakashimada, Marco A. ; Silfa, Claribel ; Cantillano, Edwin M. ; García-Silva, Jimena ; Llamas-Guillén, Beatriz A. ; Fernández-Sarmiento, Jaime ; Álvarez-Olmos, Martha I. ; Tremoulet, Adriana H. ; Álvarez-Olmos, Martha I ; Tremoulet, Adriana H ; del Águila, Olguita ; Cervi, Maria C. ; Estripeaut, Dora ; Villarreal-Treviño, Ana V. ; Ivankovich-Escoto, Gabriela ; Saltigeral-Simental, Patricia ; Villarreal-Treviño, Ana V ; Martínez-Ramírez, Rogelio O ; Gutiérrez, Iván F ; Fabi, Mariana ; Camacho-Moreno, German ; Faugier-Fuentes, Enrique ; Del Águila, Olguita ; Gutiérrez, Iván F. ; Castillo-Bustamante, David ; Cervi, Maria C ; Pérez-Camacho, Paola ; García-Domínguez, Miguel ; Aguilar, Karla L. Borjas

ObjectivesOur aim was to describe the epidemiology and outcomes of multisystem inflammatory syndrome in children (MIS-C) in Latin America.MethodsWe conducted an observational, retrospective, and prospective multicenter study that gathered information from 84 participating centers across 16 Latin American countries between August 1, 2020 and June 30, 2022.ResultsOf the 1239 reported children with MIS-C, 84.18% were previously healthy. The most frequent clinical manifestation in our studied population was abdominal pain (N = 804, 64.9%), followed by conjunctival injection (N = 784, 63.3%). The median duration of fever at the time of hospital admission was 5 days and a significant number of subjects required admission to an intensive care unit (N = 589, 47.5%). Most of the subjects (N = 1096, 88.7%) were treated with intravenous immunoglobulin, whereas 76.7% (N = 947) were treated with steroids, of whom 10.6% (N = 100) did not receive intravenous immunoglobulin. The death rate attributed to MIS-C was 4.88%, with a rate of 3.39% for those initially diagnosed with MIS-C and 8.85% for those whose admission diagnosis was not MIS-C (P <0.001, odds ratio 2.76, 95% confidence interval 1.6-4.6).ConclusionsOne of the most significant findings from our study was the death rate, especially in those not initially diagnosed with MIS-C, in whom the rate was higher. This highlights the importance of increasing awareness and making an earlier diagnosis of MIS-C in Latin America.

01 May 2024·Brazilian Journal of Otorhinolaryngology

Position paper of diagnosis and treatment of post-extubation laryngitis in children: a multidisciplinary expert-based opinion

Article

Author: Ricachinevsky, Claudia Pires ; Chone, Carlos Takahiro ; Gavazzoni, Fabiano Bleggi ; Pazinatto, Débora Bressan ; Brandão, Marcelo Barciela ; Avelino, Melissa Ameloti Gomes ; Miura, Carolina Sponchiado ; Andreolio, Cinara ; Peixoto, Fernanda Aparecida de Oliveira ; João, Paulo Ramos David ; Maunsell, Rebecca ; Possas, Silmara Aparecida ; Volpe, Daniele da Silva Jordan ; Silveira, Rita C ; Lubianca Neto, Jose Faibes ; Souza, Paula Pires de ; Ferri, Walusa Assad Gonçalves ; Caldas, Jamil Pedro de Siqueira ; Schweiger, Cláudia

OBJECTIVESTo make recommendations on the diagnosis and treatment of post-extubation laryngitis (PEL) in children with or without other comorbidities.METHODSA three-iterative modified Delphi method was applied. Specialists were recruited representing pediatric otolaryngologists, pediatric and neonatal intensivists. Questions and statements approached topics encompassing definition, diagnosis, endoscopic airway evaluation, risk factors, comorbidities, management, and follow-up. A consensus was defined as a supermajority >70%.RESULTSStridor was considered the most frequent symptom and airway endoscopy was recommended for definitive diagnosis. Gastroesophageal reflux and previous history of intubation were considered risk factors. Specific length of intubation did not achieve a consensus as a risk factor. Systemic corticosteroids should be part of the medical treatment and dexamethasone was the drug of choice. No consensus was achieved regarding dosage of corticosteroids, although endoscopic findings help defining dosage and length of treatment. Non-invasive ventilation, laryngeal rest, and use of comfort sedation scales were recommended. Indications for microlaryngoscopy and bronchoscopy under anesthesia were symptoms progression or failure to improve after the first 72-h of medical treatment post-extubation, after two failed extubations, and/or suspicion of severe lesions on flexible fiberoptic laryngoscopy.CONCLUSIONSManagement of post-extubation laryngitis is challenging and can be facilitated by a multidisciplinary approach. Airway endoscopy is mandatory and impacts decision-making, although there is no consensus regarding dosage and length of treatment.

01 Dec 2023·American Journal of Gastroenterology

S148 Long-Term Quality-of-Life and Functional Outcomes After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis

Author: Silva, Israel Goncalves ; Ribeiro da Rocha, José Joaquim ; Parra, Rogério Serafim ; Féres, Omar ; Feitosa, Marley Ribeiro ; da Costa Ferreira, Sandro

100 Deals associated with Faculdade De Medicina De Ribeirão Preto

100 Translational Medicine associated with Faculdade De Medicina De Ribeirão Preto

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 23 Nov 2024

No data posted

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

Faculdade De Medicina De Ribeirão Preto

Overview

Related

Corporation Tree

Pipeline

Pipeline Snapshot as of 23 Nov 2024

Deal

Translational Medicine

Profit

Grant & Funding(NIH)

Investment

Financing